Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19

Hydroxychloroquine and chloroquine have been proposed as treatments for coronavirus disease 2019 (Covid-19) on the basis of in vitro activity and data from uncontrolled studies and small, randomized trials. Among patients hospitalized with Covid-19, those who received hydroxychloroquine did not have a lower incidence of death at 28 days than those who received usual care.

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
Size: 624 KB